← Browse by Condition
Medical Condition
locally advanced urothelial carcinoma
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3, Phase 2, Phase 1
NCT06524544 Phase 3
Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Enrollment
320 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06265285 Phase 2
Recruiting
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Enrollment
50 pts
Location
United States
Sponsor
Mayo Clinic
NCT07492628 Phase 1
Recruiting
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
Enrollment
42 pts
Location
China
Sponsor
Beijing Biotech
NCT05269381 Phase 1, Phase 2
Recruiting
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Enrollment
132 pts
Location
United States
Sponsor
Mayo Clinic